rs200401846
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_000343.4(SLC5A1):c.1370A>G(p.Gln457Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000404 in 1,461,754 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000343.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC5A1 | NM_000343.4 | c.1370A>G | p.Gln457Arg | missense_variant | Exon 12 of 15 | ENST00000266088.9 | NP_000334.1 | |
SLC5A1 | NM_001256314.2 | c.989A>G | p.Gln330Arg | missense_variant | Exon 11 of 14 | NP_001243243.1 | ||
SLC5A1 | XM_011530331.2 | c.1281-2750A>G | intron_variant | Intron 11 of 11 | XP_011528633.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC5A1 | ENST00000266088.9 | c.1370A>G | p.Gln457Arg | missense_variant | Exon 12 of 15 | 1 | NM_000343.4 | ENSP00000266088.4 | ||
SLC5A1 | ENST00000543737.2 | c.989A>G | p.Gln330Arg | missense_variant | Exon 11 of 14 | 2 | ENSP00000444898.1 | |||
SLC5A1 | ENST00000477969.1 | n.536A>G | non_coding_transcript_exon_variant | Exon 4 of 5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251456Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135910
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461754Hom.: 1 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 727178
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
SLC5A1-related disorder Pathogenic:1
The SLC5A1 c.1370A>G variant is predicted to result in the amino acid substitution p.Gln457Arg. This variant has been reported in the homozygous state in multiple related individuals with glucose-galactose malabsorption (GGM) and was shown to co-segregate with disease in a large pedigree (Lostao MP et al 2021. PubMed ID: 34485913). Functional studies suggest that Gln457 is a critical residue within the SLC5A1 sugar-binding site and that the p.Gln457Arg substitution causes a defect in glucose transport (Loo DDF et al. 1998. PubMed ID: 9636229, Diez-Sampedro A et al. 2001. PubMed ID: 11602601; Lostao MP et al 2021. PubMed ID: 34485913). This variant is reported in 0.014% of alleles in individuals of European (Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/22-32495259-A-G). This variant is interpreted as pathogenic. -
Congenital glucose-galactose malabsorption Pathogenic:1
This sequence change replaces glutamine with arginine at codon 457 of the SLC5A1 protein (p.Gln457Arg). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and arginine. This variant is present in population databases (rs200401846, ExAC 0.02%). This variant has been observed in individual(s) with clinical features of glucose-galactose malabsorption (PMID: 9815014, Invitae). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 529229). Experimental studies have shown that this variant affects SLC5A1 protein function ‚Äã(PMID: 12139397, 19167319). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at